Company Filing History:
Years Active: 1998-2008
Title: Innovations and Contributions of Stephen S Rothman
Introduction
Stephen S Rothman is a notable inventor based in Berkeley, California, with a significant portfolio of 10 patents. His work primarily focuses on advancements in biochemistry and therapeutic methods, showcasing his commitment to innovation in the medical field.
Latest Patents
Among his latest patents, Rothman has developed carbohydrate analog inhibitors of alpha-amylase. This invention provides carbohydrate analogs that can potentially enhance the treatment of various conditions related to carbohydrate metabolism. Another significant patent involves the delivery of therapeutic gene products by intestinal cell expression. This method introduces a nucleic acid molecule encoding a secreted protein into the gastrointestinal tract, allowing for the production and secretion of the protein into the bloodstream of a mammal.
Career Highlights
Rothman has had a distinguished career, contributing to research and development at the University of California and Chymos Corporation. His work has been instrumental in advancing therapeutic techniques and understanding biochemical processes.
Collaborations
Throughout his career, Rothman has collaborated with esteemed colleagues, including Michael S German and Ira D Goldfine. These partnerships have fostered innovation and contributed to the success of his projects.
Conclusion
Stephen S Rothman exemplifies the spirit of innovation through his patents and collaborations. His contributions to the field of biochemistry and therapeutic methods continue to impact medical research and treatment options.